Discover Tenders by Glucose Glucose Products Fructose Fructose Products Sugar Sugar Products Sector

Find the most relevant tenders for Glucose Glucose Products Fructose Fructose Products Sugar Sugar Products. Access the latest tender notices from various government and private organizations published across hundreds of websites and newspapers.Obtain complete and accurate information on Glucose Glucose Products Fructose Fructose Products Sugar Sugar Products tenders, including all tender documents, RFPs, RFQs,and more. Utilize our advanced filters to search for Glucose Glucose Products Fructose Fructose Products Sugar Sugar Products tenders by organization, tender value, opening and closing dates, and more.

Filter Your Search

Country

Sector

Region

Funding Agency

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For Blood Sugar Test Strips

Deadline: 10 May 2026

Germany

Ref. No.: 5837360

EMD:Ref Document

Bid Value: Ref Document

240 Days Left

Open House Original Discount Agreements 2024 04 Cariprazine

Deadline: 30 Jun 2026

Germany

Ref. No.: 5776321

EMD:Ref Document

Bid Value: Ref Document

291 Days Left

Medicines With The Active Ingredient Rivaroxaban Atc B01Af01 In All Potencies Except 2 5 Mg Per Divided Oral Dosage Form

Deadline: 30 Apr 2026

Germany

Ref. No.: 5771252

EMD:Ref Document

Bid Value: Ref Document

230 Days Left

Medicines With The Active Ingredient Rivaroxaban Atc B01Af01 With A Potency Of 2 5 Mg Per Divided Oral Dosage Form

Deadline: 30 Apr 2026

Germany

Ref. No.: 5769473

EMD:Ref Document

Bid Value: Ref Document

230 Days Left

Medicines With The Active Ingredient Testosterone Atc G03Ba03 In The Dosage Form Injection Solution

Deadline: 30 Apr 2026

Germany

Ref. No.: 5762364

EMD:Ref Document

Bid Value: Ref Document

230 Days Left

Nga Boosting Innovative Geoint Science Technology Broad Agency Announcement Big St Baa

Deadline: 14 Dec 2026

United States

Ref. No.: 5760635

EMD:Ref Document

Bid Value: Ref Document

458 Days Left

Dps For Skills And Investment Grant Funding

Deadline: 30 Sep 2028

Great Britain

Ref. No.: 5750837

EMD:Ref Document

Bid Value: Ref Document

1114 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicines With The Active Ingredient Lipegfilgrastim L03Aa14 As Part Of A So Called Open House Model

Deadline: 30 Apr 2026

Germany

Ref. No.: 5729395

EMD:Ref Document

Bid Value: Ref Document

230 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Bevacizumab

Deadline: 10 May 2026

Germany

Ref. No.: 5728730

EMD:Ref Document

Bid Value: Ref Document

240 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Ganirelix H01Cc01 Within The Framework Of A So Called Open House Model

Deadline: 30 Apr 2026

Germany

Ref. No.: 5727688

EMD:Ref Document

Bid Value: Ref Document

230 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicines With The Active Ingredients Bismuth Subcitrate Tetracycline And Metronidazole A02Bd08 As Part Of A So Called Open Hou

Deadline: 30 Apr 2026

Germany

Ref. No.: 5723430

EMD:Ref Document

Bid Value: Ref Document

230 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Tocilizumab

Deadline: 11 May 2026

Germany

Ref. No.: 5718497

EMD:Ref Document

Bid Value: Ref Document

241 Days Left

Conclusion Not Excluding Drug Discount Agreement According To Section 130A Paragraph 8 Sgb V Through An Open House Model For The Active Ingredient Budesonide Atc Code According To Who A07Ea06

Deadline: 30 Apr 2026

Germany

Ref. No.: 5718312

EMD:Ref Document

Bid Value: Ref Document

230 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Para 8 Sgb V For The Active Ingredient Rituximab

Deadline: 11 May 2026

Germany

Ref. No.: 5716614

EMD:Ref Document

Bid Value: Ref Document

241 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicines With The Active Ingredient Follitropin Alfa G03Ga05 As Part Of A So Called Open House Model

Deadline: 30 Apr 2026

Germany

Ref. No.: 5715804

EMD:Ref Document

Bid Value: Ref Document

230 Days Left

Showing 62806 to 62820 of 63281 results

‹
1
2
...
4185
4186
4187
4188
4189
4190
4191
...
4218
4219
›

Discover Tenders by Glucose Glucose Products Fructose Fructose Products Sugar Sugar Products Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Glucose Glucose Products Fructose Fructose Products Sugar Sugar Products Sector

Filter Your Search

FREE Trial plan for all new users!